doi: 10.3748/wjg.v20.i40.14821 54 WangYParlevlietETGeerlingJJvan der TuinSJZhangHBieghsVet al
WASHINGTON A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals havent been shown to be safe or effective
doi:10.1345/aph.1K047 Passos M, Takemoto MLS, Corradino GC, Guedes LS
Br J Haematol 130(4):501-510, 2005
PDRN efficacy is supported by a 2024 clinical study (PubMed 38842633)
10.1016/S0140-6736(24)02317-1 [DOI] [PMC free article] [PubMed] 2.Ghusn W, Hurtado MD (2024) Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks